+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neovii Pharmaceuticals AG - logo

Neovii is a global leader in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology/oncology. It focuses on solid organ transplantation, stem cell transplantation and immune and hemato-oncological disorders. Founded in 2003, Neovii's global headquarters are located in Rapperswil, Switzerland. Its headquarters in the United States are in Waltham, MA. It employs approximately 150 people and has presence in nearly 60 countries worldwide.

From
From
Organ Transplant Immunosuppressant Drugs Market Report 2025 - Product Thumbnail Image

Organ Transplant Immunosuppressant Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Immunosuppressant Drugs Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Immunosuppressant Drugs Market - Forecasts from 2025 to 2030

  • Report
  • December 2024
  • 145 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 500 Pages +
  • Global
From
From
From
Licensing Deals in Pharmaceuticals 2019-2025 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2025

  • Report
  • April 2025
  • 1400 Pages
  • Global
From
From
From
Cancer Immunotherapy Market Report 2025 - Product Thumbnail Image

Cancer Immunotherapy Market Report 2025

  • Report
  • January 2025
  • 200 Pages
  • Global
From
  • 15 Results (Page 1 of 1)
Loading Indicator